108 related articles for article (PubMed ID: 11249761)
21. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer.
Wolf JK; Bodurka DC; Gano JB; Deavers M; Ramondetta L; Ramirez PT; Levenback C; Gershenson DM
Gynecol Oncol; 2004 Aug; 94(2):442-8. PubMed ID: 15297186
[TBL] [Abstract][Full Text] [Related]
22. Technology evaluation: tgDCC-E1A, targeted genetics/MD Anderson.
Wagner JA
Curr Opin Mol Ther; 1999 Apr; 1(2):266-70. PubMed ID: 11715950
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy: the challenges of translating laboratory research into clinical practice.
Connell PP; Weichselbaum RR
J Clin Oncol; 2003 Jun; 21(12):2230-1. PubMed ID: 12805319
[No Abstract] [Full Text] [Related]
24. Technology evaluation: NV-1020, MediGene.
Reinis M
Curr Opin Mol Ther; 2005 Aug; 7(4):366-75. PubMed ID: 16121703
[TBL] [Abstract][Full Text] [Related]
25. From gene therapy to virotherapy for ovarian cancer.
Stoff-Khalili MA; Dall P; Curiel DT
Minerva Ginecol; 2004 Dec; 56(6):503-14. PubMed ID: 15729203
[TBL] [Abstract][Full Text] [Related]
26. [Gene therapy in the treatment of colorectal cancer liver metastases].
Habib N; Jensen S
Bull Acad Natl Med; 2003; 187(5):893-7. PubMed ID: 14979054
[TBL] [Abstract][Full Text] [Related]
27. Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.
Pagliaro LC; Keyhani A; Williams D; Woods D; Liu B; Perrotte P; Slaton JW; Merritt JA; Grossman HB; Dinney CP
J Clin Oncol; 2003 Jun; 21(12):2247-53. PubMed ID: 12805322
[TBL] [Abstract][Full Text] [Related]
28. Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.
Bilsland AE; Anderson CJ; Fletcher-Monaghan AJ; McGregor F; Evans TR; Ganly I; Knox RJ; Plumb JA; Keith WN
Oncogene; 2003 Jan; 22(3):370-80. PubMed ID: 12545158
[TBL] [Abstract][Full Text] [Related]
29. Cancer therapy based on p53.
McCormick F
Cancer J Sci Am; 1999; 5(3):139-44. PubMed ID: 10367167
[No Abstract] [Full Text] [Related]
30. Adeno-associated virus for cancer gene therapy.
Ponnazhagan S; Curiel DT; Shaw DR; Alvarez RD; Siegal GP
Cancer Res; 2001 Sep; 61(17):6313-21. PubMed ID: 11522617
[No Abstract] [Full Text] [Related]
31. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review).
Bauerschmitz GJ; Barker SD; Hemminki A
Int J Oncol; 2002 Dec; 21(6):1161-74. PubMed ID: 12429964
[TBL] [Abstract][Full Text] [Related]
32. Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy.
Yang ZR; Wang HF; Zhao J; Peng YY; Wang J; Guinn BA; Huang LQ
Cancer Gene Ther; 2007 Jul; 14(7):599-615. PubMed ID: 17479105
[TBL] [Abstract][Full Text] [Related]
33. Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status.
Quist SR; Wang-Gohrke S; Köhler T; Kreienberg R; Runnebaum IB
Cancer Gene Ther; 2004 Aug; 11(8):547-54. PubMed ID: 15153938
[TBL] [Abstract][Full Text] [Related]
34. [Gene therapy and cancer].
Martinet O; Vallet C; Mosimann F
Rev Med Suisse Romande; 2001 Feb; 121(2):113-7. PubMed ID: 11285690
[TBL] [Abstract][Full Text] [Related]
35. The controversial role of adenoviral-derived vectors in gene therapy programs: where do we stand?
Romano G
Drug News Perspect; 2006 Mar; 19(2):99-106. PubMed ID: 16628265
[TBL] [Abstract][Full Text] [Related]
36. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
37. [Adenoviral p53 gene therapy for human lung cancer].
Fujiwara T; Tanaka N
Gan To Kagaku Ryoho; 2003 Apr; 30(4):460-7. PubMed ID: 12722675
[TBL] [Abstract][Full Text] [Related]
38. Technology evaluation: DISC.
Robertson ES
Curr Opin Mol Ther; 1999 Feb; 1(1):112-5. PubMed ID: 11249675
[TBL] [Abstract][Full Text] [Related]
39. [Gene therapy for esophageal cancer].
Shimada H; Ochiai T
Nihon Rinsho; 2005 Dec; 63 Suppl 12():517-21. PubMed ID: 16416845
[No Abstract] [Full Text] [Related]
40. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
